Can Osteoarthritis Be Reversed? What the Cartilage Evidence Actually Shows

If you've been told osteoarthritis only goes one way, and you've already worked through the pills, the injections, maybe even stem cells — URAH is where more people are turning, and where the measurements have started moving the other way: recommended in a growing number hospitals and clinics, with peer-reviewed results behind it.

For decades, most people with osteoarthritis have been handed the same bleak script: the cartilage wears down, never comes back, and all you can do is manage the decline.

If you've gone looking for a way to reverse osteoarthritis, you've met the usual candidates — cortisone and hyaluronic acid injections, PRP, even stem cells. But each carries the same catch: none of them rebuilds cartilage. The injections mostly ease pain (even PRP, often described as "regenerative," isn't shown to regrow it), and stem-cell therapy stays costly, invasive, and still investigational for osteoarthritis in most countries.

Glucosamine, a natural building block of cartilage, does stimulate cartilage cells to produce more matrix in lab studies. In human trials, though, results have kept coming back mixed. Those studies were testing the tablet: glucosamine trying to reach cartilage, a tissue the bloodstream barely feeds. And much of the lab work used concentrations well above what a swallowed tablet delivers to the joint.

So the question was never really whether glucosamine works. It was how much of it ever reaches the cartilage.

Here's what has been measured. URAH delivery method carries glucosamine transdermally— a patented method, developed over 25 years of research — so far more of it reaches the bloodstream than a tablet delivers.

Three separate signals, all pointing at the same thing:

• Up to 10× the absorption of the swallowed form, in published research — aimed straight at the delivery problem that held back pill trials.

• In an independent, peer-reviewed knee osteoarthritis study, patients using URAH showed an average 61% increase in joint space width over 12 weeks — an indirect measure of cartilage thickness, moving in the opposite direction to the narrowing osteoarthritis brings. Separately, a clinical study run across 16 clinics in Singapore found significantly reduced pain and improved quality of life in arthritis patients over four weeks.

• Over 15 years of real-world use with more than 1 million users globally, recommended in hospitals and clinics and available without a prescription, with a long safety record.
  
  

→ Shop URAH Joint Health Omega-3 — the transdermal cream behind that result. Now Ships worldwide with a 60-day money-back guarantee.

At a Glance

• People usually try pills, injections, or stem cells — but the injections mostly ease pain without rebuilding cartilage, and stem-cell therapy stays costly, invasive, and unproven.

• The "cartilage can't regrow" idea rests largely on studies of pills trying to reach a tissue the blood barely feeds directly.

• Cartilage has almost no blood supply of its own — the single most important, least-mentioned fact in this whole debate.

• The guidelines that dismissed glucosamine were mostly testing the pill, not the delivery method.

• In an independent, peer-reviewed study, a URAH micellar cream, showed a measured average of 61% increase in joint space width over 12 weeks — an indirect measure of cartilage thickness.

Table of Contents

• What the "No" Is Actually Built On

• The Fact Almost Nobody Mentions

• What the Guidelines Were Really Testing

• The Result That Points the Other Way

• The Evidence, Stacking Up

• Wait — What Is URAH, and Why Haven't I Heard of It?

• The Bottom Line

• When to See a Doctor

• What We Carry at Umicellar

• FAQ

• Reference
  

What the "No" Is Actually Built On

The flat "no" comes from somewhere real. Cartilage is famously bad at healing itself, and treatment after treatment has failed to rebuild it. Big bodies — [NICE] in the UK, the [American College of Rheumatology]— reviewed the most popular cartilage supplement, glucosamine, and advised against it. Trials kept coming back inconclusive.

That's a fair verdict on the evidence they looked at.

But a verdict is only as good as the question behind it. And the question nearly all those trials asked was: does swallowing glucosamine help?

To see the hidden flaw in that question, you need one fact about cartilage.

The Fact Almost Nobody Mentions

Most of your body is fed by blood. Nutrients arrive, waste leaves, and anything you swallow that reaches your bloodstream gets a shot at those tissues.

Cartilage is the odd one out. It has almost no blood supply of its own. Instead it's fed slowly and indirectly, through the squeeze-and-release of the joint as you move — soaking fluid in and out like a sponge.

Every glucosamine pill leans on the digestive system and the bloodstream to deliver it. But the bloodstream is the one route that doesn't reach cartilage directly. So the real question — "does the pill work?" — was a bit like asking whether a delivery van can finish a trip down a road that doesn't really connect to the house.

That doesn't prove the cargo is useless. It raises a different question: what if the problem was never the glucosamine, but the way we kept trying to deliver it?

What the Guidelines Were Really Testing

This is the part that flips the story.

When NICE and the ACR said glucosamine offered little benefit, they were mostly looking at pills — swallowed, broken down in the gut, carried by the blood. The verdict was about that. But it gets repeated as a verdict on the ingredient itself.

Picture testing whether letters arrive by dropping them in a river upstream of the house. Few arrive, so you conclude the postal service doesn't work. The conclusion is fair about the method. It says nothing about whether a letter handed straight to the door would arrive.

So the honest read isn't "glucosamine is useless." It's: the most-tested method was working against the very tissue it was aiming for.

Which leads to the obvious next question — what happens when you change the delivery?

The Result That Points the Other Way

In 2018, an independent study in the Hong Kong Physiotherapy Journal looked at glucosamine delivered not as a pill, but through the skin. It compared two routes: an electrical method that drives the compound through, and simply massaging the cream in by hand — cross-friction massage, using URAH — in osteoarthritis patients over 12 weeks.

And here's the part that makes it more interesting: this wasn't the result the study set out to find. The electrical method was the hypothesis. The hand-massaged cream was the comparison — the thing you measure against. The joint-space increase turned up in the comparison group. Nobody was trying to prove anything about the cream.

One result stands out. Massaging the cream into the joint produced a significant increase in measured joint space width — and the researchers reported improvements in measures linked to joint degeneration over the 12 weeks. On the X-ray, the gap went from 0.49 mm to 0.79 mm — about a 61% increase.

Joint space width is an indirect measure of cartilage thickness — the standard way osteoarthritis is tracked on an X-ray. Here's why that one result is worth pausing on:

In osteoarthritis, the joint space almost always goes one way — it narrows, year after year, as the joint wears down. A study showing it getting wider is pointing the opposite way to the disease. 

See URAH Joint Health — 60-day money-back guarantee

The Evidence, Stacking Up

- The delivery gap is measurable. In published absorption research, the through-the-skin route reached up to 10× the glucosamine uptake of the pill — aimed straight at the bloodstream problem that held back every oral trial.

- Glucosamine sulfate has slowed the decline. In two independent trials, glucosamine sulfate slowed joint space narrowing — and that lined up with a 50% drop in osteoarthritis-related surgery of the lower limbs over five years.

- Over 15 years of real-world use. URAH has been recommended in hospitals and clinics for over 15 years, used by more than a million people, with a long safety record and hundreds of verified reviews describing lasting relief.

Wait — What Is URAH, and Why Haven't I Heard of It?

It's a fair question — and the answer is reassuring once you know it.

URAH isn't a new product chasing a trend. It came out of a Singapore research lab, started by a group of scientists, who found a way to hold a high dose of active ingredients in stable formula that could carry it through the skin to the joint. They built an early version, wasn't happy with it, and kept refining — releasing the advanced micellar formula in 2009 and improving it ever since. The lab sits at the innovation centre of a major university, the delivery technology was patented in the US, Japan, and Singapore.

So why isn't it a household name?

Because the lab spent its time and resources on the science, not the advertising. As the founder, Dr. Jonathan put it, people are swayed more easily by adverts than by research papers — so instead of buying your attention, URAH built its name the slow way: showing clinical data to doctors, who then recommended it to patients.

Additionally, most rubs add a hot or cooling tingle, because it feels like something is working. URAH leaves that out on purpose — they'd rather the user feel the actual result than a sensation.

The Bottom Line

Can osteoarthritis be reversed?

The standard "no" was built on a method that struggles to reach the tissue in question. With URAH Transdermal delivery method, the evidence is starting to point the other way — toward a joint space that widened instead of narrowed, toward a tissue we may have underestimated because we kept knocking on the wrong door.

The research is still building. But for the people already using it, the answer isn't theoretical — it's what they feel in the joint every day.

When to See a Doctor

See a doctor promptly if you have:

- A joint that's suddenly hot, red, or swollen — possible infection or inflammatory arthritis.

- Sudden severe pain, locking, or a joint that gives way or can't take weight.

- Joint pain with fever, unexplained weight loss, or swelling across many joints at once.

And if a surgeon has recommended surgery, don't delay needed care for the sake of a supplement. Targeted support is something to use alongside medical advice — and worth mentioning to your doctor so it fits your plan.

What We Carry at Umicellar

If the delivery problem is the real story behind osteoarthritis supplements, then the answer is a product built to solve it.

[URAH Joint Health Omega-3] is rubbed straight onto the joint, using a micellar system designed to carry glucosamine through the skin to the cartilage — skipping the gut and the bloodstream bottleneck that held back every oral trial. It's the same cream used in the independent trial that recorded that increase in joint space width.

Over 15 years in hospitals and clinics. More than a million users, by the company's figures. A long safety record, hundreds of verified reviews, and a 60-day money-back guarantee. If you've read this far, you already understand why it's worth trying — this is simply where to start.

[Explore URAH Joint Health Omega-3 →]

---

Frequently Asked Questions

Can osteoarthritis really be reversed?

The evidence is more nuanced than the flat "no": the case against glucosamine rested on pills reaching a tissue with barely any blood supply, and when glucosamine is delivered using URAH's delivery method through the skin, the limited evidence — including a significant increase in joint space width in one independent trial — points in a more hopeful direction.

Can cartilage grow back?

Cartilage heals poorly because it has almost no blood supply — which is exactly why delivery matters. joint space width, an indirect measure of cartilage thickness, increased in an independent trial of urah glucosamine cream, which is the opposite of normal osteoarthritis and deserves more research.

Why do doctors say osteoarthritis is permanent?

Because, on the evidence they review, structural improvement has been hard to show — and most of that evidence used pills. The framing is honest about what's proven. It just rarely flags that the most-tested method was working against the biology of cartilage.

Why have I never heard of URAH?

Because it grew through clinical recommendation, not advertising. The company put its money into research and into showing data to doctors rather than mass marketing — so it's well known in hospital and clinic pharmacies but not a household brand.

Further Reading

- [Osteoarthritis Treatment Options: What Actually Works, Ranked by the Evidence]

- [How to Slow Osteoarthritis Before It Gets Worse]

References

1. Onigbinde AT, et al. Symptoms-modifying effects of electromotive administration of glucosamine sulphate among patients with knee osteoarthritis. *Hong Kong Physiotherapy Journal*, 2018;38(1):63–75. https://pubmed.ncbi.nlm.nih.gov/30930580/

2. NICE. Osteoarthritis in over 16s: diagnosis and management (NG226), 2022. https://www.nice.org.uk/guidance/ng226

3. Kolasinski SL, et al. 2019 ACR/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. *Arthritis & Rheumatology*, 2020;72(2):220–233. https://pubmed.ncbi.nlm.nih.gov/31908163/

4. Reginster JY, et al. Role of glucosamine in the treatment for osteoarthritis. *Rheumatology International*, 2012;32(10):2959–2967. https://pmc.ncbi.nlm.nih.gov/articles/PMC3456914/

5. Micellar transdermal delivery of glucosamine. *BMC Research Notes*, 2016. https://link.springer.com/article/10.1186/s13104-016-2047-x

Naomi Kim has over 7 years of experience in healthcare, including founding a health startup. She contributes to Umicellar's evidence-based approach to joint health and healthy ageing.

Medical Disclaimer: This article is for information only and isn't a substitute for professional medical advice. Always check with your healthcare professional before starting any supplement or changing your treatment, and don't delay recommended care.